Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Article - 19/01/2008

    Zeiss continues fourth year of dynamic development

    Sales revenues of the Carl Zeiss Group rose by seven per cent to 2604 million. The growth posted for EbIT Earnings before Interest and Taxes increased by 26 per cent to 394 million. Zeiss AG is thus continuing the series of successes that has lasted for four years.

    https://www.gesundheitsindustrie-bw.de/en/article/news/zeiss-continues-fourth-year-of-dynamic-development
  • Press release - 19/01/2008

    New Microbial Genome-to-Array Service

    Partnering with Prognosys Biosciences febit offers a new Genome-to-Array Service. This Service gives scientists access to the latest technology and know-how in sequencing and microarrays even for DNA where no standard microarrays are available.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-microbial-genome-to-array-service
  • Article - 15/01/2008

    Female hearts fibrillate differently

    Gender-specific differences are currently not only a subject of debate for experts but have also raised broad media interest. However there are very few specific investigations that are able to provide a clear answer said Prof. Volker Kühlkamp chief physician in the Department of CardiologyElectrophysiology at the Lake Constance Heart Centre in ConstanceKreuzlingen and specialist in cardiac arrhythmia.

    https://www.gesundheitsindustrie-bw.de/en/article/news/female-hearts-fibrillate-differently
  • Press release - 15/01/2008

    ALVESCO® gains FDA approval for the U.S. market

    The Food and Drug Administration approved Nycomeds ALVESCO ciclesonide Inhalation Aerosol in the United States for the maintenance treatment of asthma and as prophylactic therapy in adult and adolescent patients aged 12 years and older.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/alvesco-gains-fda-approval-for-the-u-s-market
  • Press release - 14/01/2008

    Industrial healthcare degree courses in Tuttlingen

    New degree courses look set to complement Baden-Württembergs higher education landscape. The Council of Ministers took the decision to establish a Furtwangen University of Applied Sciences department in Tuttlingen.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/industrial-healthcare-degree-courses-in-tuttlingen
  • Article - 14/01/2008 Laying the foundation stone for the new building (from left to right): Dr. Christoph Gaissmaier, Dr. Jürgen Fritz (both on the managing board of TETEC AG), Prof. Drs. Michael Ungethüm, Dr. Harald Stallforth (both on the managing board of Aesculap AG & Co. KG).

    Tetec AG to erect new building in Reutlingen

    Tetec AG a leader in regenerative medicine is building a new facility in ReutlingenKusterdingen in which Aesculap AG is the only investor. This construction represents a major progress for the Medical technology and health TuttlingenNeckar-Alb top cluster.

    https://www.gesundheitsindustrie-bw.de/en/article/news/tetec-ag-to-erect-new-building-in-reutlingen
  • Press release - 14/01/2008

    Prostate cancer: Improving the success of treatment

    Prostate cancer is the most frequent malignant tumour in men. Researchers from Freiburg and Bonn have succeeded in developing the basics for new therapies in particular for the treatment of advanced prostate cancer.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/prostate-cancer-improving-the-success-of-treatment
  • Press release - 13/01/2008

    Thrombosis in the brain

    Researchers led by a scientist at the Department of Neurology at the University Hospital in Heidelberg has identified a new gene variant as a risk factor for cerebral venous thromboses. 16.7 per cent of patients with cerebral venous thrombosis had the new variant compared to only 5.5 per cent of the healthy population.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/thrombosis-in-the-brain
  • Article - 12/01/2008

    Peptide chips for improved cancer diagnostics

    Scientists at the German Cancer Research Centre DKFZ have now succeeded in generating peptides on a microchip - faster and thus cheaper than with previous methods.

    https://www.gesundheitsindustrie-bw.de/en/article/news/peptide-chips-for-improved-cancer-diagnostics
  • Press release - 10/01/2008

    Genetic Testing of IVF Embryos

    A new report by European Commission scientists gives a full picture of preimplantation genetic diagnosis PGD. Parents need better information on genetic testing of IVF embryos.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/genetic-testing-of-ivf-embryos
  • Press release - 08/01/2008

    How thoughts are generated

    What is a thought? First of all it is a firework of neuronal activity produced by the neurons which encode and transmit information as electrical impulses. However when we think or remember something there is not always an input from the environment.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-thoughts-are-generated
  • Article - 07/01/2008 Portrait of professor doctor Thomas Hirth

    Thomas Hirth becomes new director of the Fraunhofer IGB

    Prof. Dr. Thomas Hirth took over the management of the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB in Stuttgart. In 1992 he became a scientist at the Fraunhofer Institute for Chemical Technology ICT in Karlsruhe.

    https://www.gesundheitsindustrie-bw.de/en/article/news/thomas-hirth-becomes-new-director-of-the-fraunhofer-igb
  • Article - 07/01/2008

    Service Provider Competition 2008

    The deadline for submitting applications is the 14th March 2008.

    https://www.gesundheitsindustrie-bw.de/en/article/news/service-provider-competition-2008
  • Article - 07/01/2008

    Fighting an unknown killer with knowledge

    In Germany every year 800000 people contract community acquired pneumonia and 50000 die of it. A new foundation based in Ulm is hoping to contribute to a better understanding of this unpleasant disease and to improve the therapy to combat it.

    https://www.gesundheitsindustrie-bw.de/en/article/news/fighting-an-unknown-killer-with-knowledge
  • Article - 07/01/2008

    Capital in the brain: support and advice in drug approval processes

    In his profession age and experience are decisive advantages Dr. Mohamed Baccouche 57 consults pharmaceutical companies worldwide on the development and approval of new drug substances.

    https://www.gesundheitsindustrie-bw.de/en/article/news/capital-in-the-brain-support-and-advice-in-drug-approval-processes
  • Press release - 07/01/2008

    TachoSil® to be marketed in the Unites States by Baxter

    Nycomed grants Baxter International Inc. NYSE BAX exclusive rights to market and distribute Nycomeds TachoSil patch in the United States. The agreement is part of Nycomeds strategy to seek marketing and commercialisation partnerships for the US market instead of operating its own sales force.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/tachosil-to-be-marketed-in-the-unites-states-by-baxter
  • Press release - 06/01/2008

    Heart catheter examinations - an elegant method with huge potential

    The method is elegant and cardiologists love it heart catheter examination. The number of catheter examinations carried out has continuously increased over the last few years. In 2005 in Germany an impressive number of 772000 heart catheter examinations were carried out.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/heart-catheter-examinations-an-elegant-method-with-huge-potential
  • Article - 06/01/2008

    gematik certifies Hospital Connector

    The server-based Hospital Connector developed by InterComponentWare AG ICW has now been certified by the German company responsible for the operation and application of the national Electronic Health Card in the official health card test regions.

    https://www.gesundheitsindustrie-bw.de/en/article/news/gematik-certifies-hospital-connector
  • Press release - 06/01/2008

    20 years of pharmaceutical technology

    The Albstadt-Sigmaringen University of Applied Sciences was the first to offer a pharmaceutical technology course back in 19871988. The course has become a great success and the graduates are sought after in both the pharmaceutical and medical technology industries.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/20-years-of-pharmaceutical-technology
  • Article - 06/01/2008

    Heinrich Planck: experienced interdisciplinarity

    Only a few researchers combine different disciplines as effectively and with as much flair as Professor Dr.-Ing. Heinrich Planck director of the ITV Denkendorf. He combines mechanical textile and medical engineering both on the scientific and economic level at the same time as being a dedicated networker.

    https://www.gesundheitsindustrie-bw.de/en/article/news/heinrich-planck-experienced-interdisciplinarity
  • Article - 05/01/2008

    MicroRNA switches off tumour protection

    The microRNA miR-21 suppresses the production of tumour suppressor Pdcd4 which protects cells from developing cancer. Researchers at the DKFZ have now found out that colorectal cancer cells in particular lack Pdcd4 while these cells have an oversupply of miR-21.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/microrna-switches-off-tumour-protection
  • Press release - 05/01/2008

    Nycomed files marketing authorisation application for fentanyl spray

    Nycomed filed a marketing authorisation application with the European Medicines Agency for an intranasal fentanyl spray in Europe. If approved the centralised filing could allow Nycomed to be the first to enter the market in 29 European countries with the fentanyl spray.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/nycomed-files-marketing-authorisation-application-for-fentanyl-spray
  • Press release - 04/01/2008

    EKD chairman Huber supports relaxation of stem cell research regulations

    According to experts the currently available cell lines are contaminated and cannot be used for the intended research purposes. Therefore the one-time shifting of the key date seems justifiable said Huber to the Passauer Neue Presse a german newspaper.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/ekd-chairman-huber-supports-relaxation-of-stem-cell-research-regulations
  • Article - 04/01/2008

    Karlsruhe Institute of Technology (KIT) established

    The University of Karlsruhe and the Karlsruhe Research Centre have set up the Karlsruhe Institute of Technology KIT. The signing of the cooperation agreement is the first milestone on the way to a total merger which both partners hope will eventually become reality.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/karlsruhe-institute-of-technology-kit-established
  • Press release - 03/01/2008

    University medicine - just a mouse click away

    The German medical faculties and the associated university hospitals are now presenting their activities on the Internet by way of the Landkarte Hochschulmedizin University Medicine Map.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/university-medicine-just-a-mouse-click-away

Page 119 / 120

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • …
  • 116
  • 117
  • 118
  • 119
  • 120
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2023
Website address: https://www.gesundheitsindustrie-bw.de/en/search